Tiansuo Zhao
Tianjin Medical University Cancer Institute and Hospital(CN)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer, Hypoxia, and Metabolism, Cancer Research and Treatments, RNA modifications and cancer, Cancer Genomics and Diagnostics
Most-Cited Works
- → Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma(2016)232 cited
- → Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma(2014)138 cited
- → Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression(2017)137 cited
- → Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice(2017)112 cited
- → LASP1 Is a HIF1α Target Gene Critical for Metastasis of Pancreatic Cancer(2014)101 cited
- → Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis(2023)75 cited
- → BZW1 Facilitates Glycolysis and Promotes Tumor Growth in Pancreatic Ductal Adenocarcinoma Through Potentiating eIF2α Phosphorylation(2021)67 cited
- → ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin(2016)66 cited
- → IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer(2020)61 cited
- → LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen–Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation(2019)54 cited